Literature DB >> 16390262

A novel method for somatic cell nuclear transfer to mouse embryonic stem cells.

Danièle Pralong1, Krzysztof Mrozik, Filomena Occhiodoro, Nishanthi Wijesundara, Huseyin Sumer, Antonius L Van Boxtel, Alan Trounson, Paul J Verma.   

Abstract

Nuclear reprogramming by somatic cell nuclear transfer (SCNT) provides a practical approach for generating autologous pluripotent cells from adult somatic cells. It has been shown that murine somatic cells can also be reprogrammed to a pluripotent-like state by fusion with embryonic stem (ES) cells. Typically, the first step in SCNT involves enucleation of the recipient cell. However, recent evidence suggests that enucleated diploid ES cells may lack reprogramming capabilities. Here we have developed methods whereby larger tetraploid ES cells are first generated by fusion of two mouse ES cell lines transfected with plasmids carrying different antibiotic-resistance cassettes, followed by double antibiotic selection. Tetraploid ES cells grown on tissue culture disks or wells can be efficiently enucleated (up to 99%) using a combination of cytochalasin B treatment and centrifugation, with cytoplasts generated from these cells larger than those obtained from normal diploid ES cells. Also, we show that the enucleation rate is dependent on centrifugation time and cell ploidy. Further, we demonstrate that normal diploid ES cells can be fused to tetraploid ES cells to form heterokaryons, and that selective differential centrifugation conditions can be applied where the tetraploid nucleus is removed while the diploid donor nucleus is retained. This technology opens new avenues for generating autologous, diploid pluripotent cells, and provides a dynamic model for studying nuclear reprogramming in ES cells.

Entities:  

Mesh:

Year:  2005        PMID: 16390262     DOI: 10.1089/clo.2005.7.265

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  7 in total

1.  Recipient cell nuclear factors are required for reprogramming by nuclear transfer.

Authors:  Dieter Egli; Kevin Eggan
Journal:  Development       Date:  2010-05-12       Impact factor: 6.868

Review 2.  Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome.

Authors:  Danièle Pralong; Alan O Trounson; Paul J Verma
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

3.  Functional evaluation of ES-somatic cell hybrids in vitro and in vivo.

Authors:  Huseyin Sumer; Kitai Kim; Jun Liu; Kitwa Ng; George Q Daley; Paul J Verma
Journal:  Cell Reprogram       Date:  2014-05-02       Impact factor: 1.987

4.  Chromosomal and telomeric reprogramming following ES-somatic cell fusion.

Authors:  Huseyin Sumer; Craig Nicholls; Alexander R Pinto; Dinesh Indraharan; Jun Liu; Mei Ling Lim; Jun-Ping Liu; Paul J Verma
Journal:  Chromosoma       Date:  2009-11-11       Impact factor: 4.316

Review 5.  Interspecies somatic cell nuclear transfer and preliminary data for horse-cow/mouse iSCNT.

Authors:  R Tayfur Tecirlioglu; Jitong Guo; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

6.  Human therapeutic cloning (NTSC): applying research from mammalian reproductive cloning.

Authors:  Andrew J French; Samuel H Wood; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

7.  Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.

Authors:  Carlos F Pereira; Rémi Terranova; Natalie K Ryan; Joana Santos; Kelly J Morris; Wei Cui; Matthias Merkenschlager; Amanda G Fisher
Journal:  PLoS Genet       Date:  2008-09-05       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.